LCFA: Lung Cancer Foundation of America

06/09/2026

Colette Smith shares why raising awareness matters and how greater attention can help drive research forward for those diagnosed today and in the future.

Read Colette's story here: lcfamerica.org/story/transforms-experience-into-community-action/

06/07/2026

This National Cancer Survivors Day, we celebrate lung cancer survivors and the research helping more people live longer and better.

Read stories from people living with lung cancer and learn more about their experiences at lcfamerica.org/living-with-lung-cancer/stories-of-hope/

06/06/2026

Understanding how treatment may affect everyday life is an important part of navigating an extensive-stage small cell lung cancer diagnosis. Patient advocate Jill Feldman and Dr. Martin Edelman discuss the importance of asking questions about clinical trials and emerging treatment options. Listen to the latest Hope With Answers episode here: https://bit.ly/4x5RpQa

06/05/2026

Small cell lung cancer treatment continues to evolve, but questions remain about who benefits most from ongoing therapy. In the latest Hope With Answers episode, patient advocate Jill Feldman and Dr. Martin Edelman discuss how emerging treatments may influence outcomes and offer new hope for patients.

Listen to the new Hope With Answers episode: https://bit.ly/4x5RpQa

06/05/2026

Our new Hope with Answers podcast will feature Jill Feldman, a patient advocate, in conversation with Dr. Martin Edelman, an MD. https://bit.ly/4x5RpQa

06/04/2026

Tune in for a new Hope with Answers podcast about maintenance therapy! What has your experience of maintenance therapy been like? https://bit.ly/4nEjM39

06/03/2026

06/02/2026

Lung cancer doesn't discriminate. As Clara Mae Cirks reminds us, if you have lungs, you can get lung cancer. Raising awareness and challenging misconceptions can help more people understand their risk and recognize the importance of early detection. Learn more at LCFAmerica.org.

06/01/2026

At ASCO 2026, we're reminded just how far lung cancer research has come.

Our President, Kim Norris, reflects on her first ASCO in 2009, when the entire lung cancer community could fit into a single breakout room. Today, lung cancer research is featured on some of the biggest stages at ASCO, a reflection of the incredible progress driven by targeted therapies, immunotherapy, and the researchers dedicated to changing patient outcomes.

Seeing that growth firsthand is a powerful reminder of why we do this work. There has never been more hope in lung cancer, and we're proud to support the research and researchers helping move the field forward.